These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 28646947)

  • 1. Measles, immune suppression and vaccination: direct and indirect nonspecific vaccine benefits.
    Mina MJ
    J Infect; 2017 Jun; 74 Suppl 1():S10-S17. PubMed ID: 28646947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune responses to measles and measles vaccine: challenges for measles control.
    Moss WJ; Polack FP
    Viral Immunol; 2001; 14(4):297-309. PubMed ID: 11792060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-specific effects of childhood vaccinations - A case control study nested into a Health and Demographic Surveillance System in rural Burkina Faso.
    Pfeiffer G; Fisker AB; Nebié E; Hengelbrock J; Sié A; Becher H; Müller O
    Vaccine; 2017 Dec; 35(51):7114-7120. PubMed ID: 29153586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles vaccination: new strategies and formulations.
    de Vries RD; Stittelaar KJ; Osterhaus AD; de Swart RL
    Expert Rev Vaccines; 2008 Oct; 7(8):1215-23. PubMed ID: 18844595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality.
    Mina MJ; Metcalf CJ; de Swart RL; Osterhaus AD; Grenfell BT
    Science; 2015 May; 348(6235):694-9. PubMed ID: 25954009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of an Early Dose of Measles Vaccine on Morbidity Between 18 Weeks and 9 Months of Age: A Randomized, Controlled Trial in Guinea-Bissau.
    Do VA; Biering-Sørensen S; Fisker AB; Balé C; Rasmussen SM; Christensen LD; Jensen KJ; Martins C; Aaby P; Benn CS
    J Infect Dis; 2017 Apr; 215(8):1188-1196. PubMed ID: 28077730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles virus.
    Naim HY
    Hum Vaccin Immunother; 2015; 11(1):21-6. PubMed ID: 25483511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles in the United Kingdom 1990-2008 and the effectiveness of measles vaccines.
    Jick H; Hagberg KW
    Vaccine; 2010 Jun; 28(29):4588-92. PubMed ID: 20470793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles still spreads in Europe: who is responsible for the failure to vaccinate?
    Carrillo-Santisteve P; Lopalco PL
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():50-6. PubMed ID: 23051058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is global measles eradication feasible?
    de Quadros CA
    Curr Top Microbiol Immunol; 2006; 304():153-63. PubMed ID: 16989269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.
    Chiu HH; Lee CY; Chih TW; Lee PI; Chang LY; Lin YJ; Hsu CM; Huang LM
    J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update: global measles control and mortality reduction--worldwide, 1991-2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 May; 52(20):471-5. PubMed ID: 12807081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intranasal vaccination with live measles vaccines within the framework of measles eradication strategy].
    Liashchenko VA; Iuminova NV
    Vopr Virusol; 2002; 47(3):7-10. PubMed ID: 12173439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress Toward Regional Measles Elimination - Worldwide, 2000-2016.
    Dabbagh A; Patel MK; Dumolard L; Gacic-Dobo M; Mulders MN; Okwo-Bele JM; Kretsinger K; Papania MJ; Rota PA; Goodson JL
    MMWR Morb Mortal Wkly Rep; 2017 Oct; 66(42):1148-1153. PubMed ID: 29073125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination against measles: a neverending story.
    Stittelaar KJ; de Swart RL; Osterhaus AD
    Expert Rev Vaccines; 2002 Aug; 1(2):151-9. PubMed ID: 12901554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eradication of measles: remaining challenges.
    Holzmann H; Hengel H; Tenbusch M; Doerr HW
    Med Microbiol Immunol; 2016 Jun; 205(3):201-8. PubMed ID: 26935826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
    Gans HA; Yasukawa LL; Alderson A; Rinki M; DeHovitz R; Beeler J; Audet S; Maldonado Y; Arvin AM
    J Infect Dis; 2004 Jul; 190(1):83-90. PubMed ID: 15195246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspective on Global Measles Epidemiology and Control and the Role of Novel Vaccination Strategies.
    Coughlin MM; Beck AS; Bankamp B; Rota PA
    Viruses; 2017 Jan; 9(1):. PubMed ID: 28106841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measles vaccination and reduced child mortality: Prevention of immune amnesia or beneficial non-specific effects of measles vaccine?
    Benn CS; Aaby P
    J Infect; 2023 Oct; 87(4):295-304. PubMed ID: 37482223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consequences of incomplete measles vaccine uptake in healthcare workers during an outbreak in North East England.
    Bogowicz P; Waller J; Wilson D; Foster K
    J Hosp Infect; 2014 Feb; 86(2):144-6. PubMed ID: 24418651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.